Author:
Omata Yasunori,Hagiwara Futoshi,Nishino Jinju,Matsudaira Ko,Kadono Yuho,Juji Takuo,Mori Toshihito,Nakayama Hisanori,Nagase Yuichi,Hirose Jun,Yasui Tetsuro,Matsumoto Takumi,Matsui Toshihiro,Tohma Shigeto,Tanaka Sakae
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Orthopedics and Sports Medicine,General Medicine,Endocrinology, Diabetes and Metabolism
Reference33 articles.
1. Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423:356–361
2. Yamanaka H, Sugiyama N, Inoue E, Taniguchi A, Momohara S (2013) Estimates of the prevalence of and current treatment practices for rheumatoid arthritis in Japan using reimbursement data from health insurance societies and the IORRA cohort (I). Mod Rheumatol. doi: 10.1007/s10165-013-0863-6
3. Tanaka S (2007) Signaling axis in osteoclast biology and therapeutic targeting in the RANKL/RANK/OPG system. Am J Nephrol 27:466–478
4. Fautrel B, Guillemin F (2002) Cost of illness studies in rheumatic diseases. Curr Opin Rheumatol 14:121–126
5. Furneri G, Mantovani LG, Belisari A, Mosca M, Cristiani M, Bellelli S, Cortesi PA, Turchetti G (2012) Systematic literature review on economic implications and pharmacoeconomic issues of rheumatoid arthritis. Clin Exp Rheumatol 30:S72–S84
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献